What's Going On With Ginkgo Bioworks (DNA) Stock?

Ginkgo Bioworks Holdings, Inc. DNA shares traded higher Wednesday. The company announced that Voodoo Scientific will utilize Ginkgo Enzyme Services to optimize an enzymatic solution to allow distillers to produce ultra-premium spirits.

What To Know: Voodoo Scientific has created a solution that allows distillers to manage the harsh sensation produced by most distilled alcoholic beverages.

The breakthrough could extend itself to new flavor profiles across the full range of spirits types without affecting other components of the beverage's flavor profile.

Ginkgo will utilize its substantial expertise in protein discovery and design to assist in the advancement of the crucial enzyme required for Voodoo's product. The aim is to design and enhance the enzyme to effectively cater to various conditions encountered in the production of spirits.

"Providing distillers with a means to eliminate, or control, the harshness of their spirits products is very gratifying." said Joana Montenegro, co-founder and CSO at Voodoo.

"Ginkgo was the best choice of partners for us among the ones we considered because of their unique combination of strong scientific capabilities and a business model that fits an early-stage company like ours."

Related Link: Why Regeneron Stock Is Trading Lower Today

DNA Price Action: Shares of DNA closed Wednesday up 13.8% at $1.82, according to Benzinga Pro.

Image by Konstantin Kolosov from Pixabay